Business Wire

Thales Alerts on the Risks Linked to Cybercrime in Its New Edition of the “CyberThreat Handbook: organised cybercrime”

12.10.2020 15:30:00 EEST | Business Wire | Press release

Share

For the 2020 edition of Les Assises de la Sécurité, Thales launches the newest edition of its CyberThreat Handbook, this year dedicated to cybercriminals. Thales’ experts unveil their analysis and conclusions when it comes to cybercrime, an extremely dangerous network with a large number of hackers groups. Interactions and permanent movements unite organised cybercrime and bring it to life. Without protection or proactive means, the attacks of cybercriminals will create each time more damage. To face their always-evolving technics, a better understanding of the threat is key; advanced tools and services such as Threat Intelligence are an asset to anticipate this threat as much as possible.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201012005432/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

CyberThreant Handbook Cybercrime (Photo: Thales)

By interacting as a network of cybercrime groups, cybercriminals are able to function increasingly effectively: each group specialises in a particular area, and the different groups collaborate to benefit from each other’s expertise. It is this specialisation that makes cybercriminals more effective, allowing them to concentrate on a given type of attack, while drawing on know-how from within the network.

Various groups of the most technically adept cyber attackers, with highly sophisticated compromise strategies and substantial financial resources, head this organisation. These are the “Big Game Hunters”, whose tactics, techniques and procedures (TTPs) and technical infrastructure are similar to certain state-sponsored hacking groups. They attack specific targets, such as political institutions and major companies, using ransomware to demand large sums.

To achieve their objectives, cybercriminals use a combination of technical expertise and the panic that they sow in companies and institutions. Panic can have a devastating impact in terms of the consequences of an attack. It is vital not to give in to threats or blackmail. Cybercriminals’ targets are extremely diverse and opportunistic; any organization can suffer from it. Thales’ experts strongly recommend bearing in mind that anyone can be a target in order to be prepared and to adopt a clear and detailed cyber crisis strategy.

Surprisingly, 60% of these huge revenues come from illegal online markets, 30% from theft of intellectual property and trade secrets and only 0.07% from ransomware which however do the most damage. With revenues estimated up to $1.5 trillion a year 1– meaning 1.5 times more income (as an annual average) than counterfeiting, and 2.8 times more than the illegal drugs trade – this network is a whole economic system that can now endanger any company or organization with severe consequences on the world’s economy.

For more information, download the press kit here and the report here.

About Thales

Thales (Euronext Paris: HO) is a global technology leader shaping the world of tomorrow today. The Group provides solutions, services and products to customers in the aeronautics, space, transport, digital identity and security, and defence markets. With 83,000 employees in 68 countries, Thales generated sales of €19 billion in 2019.

Thales is investing in particular in digital innovations — connectivity, Big Data, artificial intelligence and cybersecurity — technologies that support businesses, organisations and governments in their decisive moments.

FOR MORE INFORMATION

Thales Group
Cybersecurity


1 Research by the Cybersecurity firm Bromium, and Dr Mike McGuire, a researcher in criminology at the University of Surrey (UK)

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Thales, Media relations
Security
Constance Arnoux
+33 (0)6 44 12 16 35
constance.arnoux@thalesgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 11:22:00 EET | Press release

Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh

Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f

Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye